Showing results (81-90 of 96) with videos related to
Sort By:
Pageof 10
Monoclonal Antibodies in Immunodiagnosis and Immunotherapy|April 10, 2020
Development of Novel Mouse Monoclonal Antibodies Against Human CD19Shinji Yamada, Mika K Kaneko, Yusuke Sayama, et al.European Journal of Cancer (Oxford, England : 1990)|July 15, 2019
Predictive and prognostic value of stromal tumour-infiltrating lymphocytes before and after neoadjuvant therapy in triple negative and HER2-positive breast cancerTomohiro Ochi, Giampaolo Bianchini, Michiko Ando, et al.Monoclonal Antibodies in Immunodiagnosis and Immunotherapy|May 27, 2021
Development of Monoclonal Antibody PMab-269 Against California Sea Lion PodoplaninTomohiro Tanaka, Teizo Asano, Masato Sano, et al.Monoclonal Antibodies in Immunodiagnosis and Immunotherapy|August 13, 2019
Characterization of Anti-Goat Podoplanin Monoclonal Antibody PMab-235 Using Immunohistochemistry Against Goat TissuesJunko Takei, Shunsuke Itai, Hiroyuki Harada, et al.Monoclonal Antibodies in Immunodiagnosis and Immunotherapy|February 28, 2022
Defucosylated Anti-Epidermal Growth Factor Receptor Monoclonal Antibody (134-mG2a-f) Exerts Antitumor Activities in Mouse Xenograft Models of Canine OsteosarcomaRen Nanamiya, Junko Takei, Tomokazu Ohishi, et al.Breast Cancer (Tokyo, Japan)|May 13, 2026
Prevalence and clinical significance of germline pathogenic variants identified by multigene panel testing in high-risk Japanese patients with breast cancerMiharu Kano, Kanae Taruno, Mayuko Inuzuka, et al.Breast Cancer (Tokyo, Japan)|July 13, 2024
High-risk pathogenic germline variants in blood relatives of BRCA1/2 negative probandsReiko Yoshida, Tomoko Kaneyasu, Arisa Ueki, et al.The Journal of Pathology|January 30, 2022
Phosphorylation of hTERT at threonine 249 is a novel tumor biomarker of aggressive cancer with poor prognosis in multiple organsYoko Matsuda, Taro Yamashita, Juanjuan Ye, et al.NPJ Breast Cancer|June 23, 2020
Prevalence of disease-causing genes in Japanese patients with BRCA1/2-wildtype hereditary breast and ovarian cancer syndromeTomoko Kaneyasu, Seiichi Mori, Hideko Yamauchi, et al.Journal of Medical Genetics|March 19, 2026
Comprehensive evidence for the pathogenicity of the BRCA2 c.7847C>T (p.Ser2616Phe) variant specific to the Japanese populationKazuki Yamazawa, Arisa Ueki, Asami Kuga, et al.Pageof 10